Granules India Ltd - 532482 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Granules India Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here GRANULES INDIA LTD.-$ - 532482 - Intimation Of Record Date For Buyback Of Upto 1,25,00,000 Fully Paid Equity Shares Of The Company Of Face Value Of Re.1/- Each At A Price Of INR 200 Per Share Aggregating Up To INR 250,00,00,000
Intimation of Record date for buyback of upto 1,25,00,000 fully paid equity shares of the Company of face value of Re.1/- each at a price of INR 200 per share aggregating up to INR 250,00,00,000 GRANULES INDIA LTD.-$ - 532482 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for IDBI Trusteeship Services Ltd GRANULES INDIA LTD.-$ - 532482 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 05, 2020 for Krishna Prasad Chigurupati and Uma Devi Chigurupati
Granules India share price gains 4% on USFDA nod
The company now have a total of 24 ANDA approvals from US FDA (22 Final approvals and 2 tentative approvals). GRANULES INDIA LTD.-$ - 532482 - Granules Pharmaceuticals, Inc. Received US FDA Approval For Potassium Chloride Extended-Release Tablets USP.
Granules Pharmaceuticals, Inc. received US FDA approval for Potassium Chloride Extended-Release Tablets USP. Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Investor Meeting GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Investor Meeting Why Granules India is still a good pharma pick
The stock of active ingredients and drug formulations maker Granules India has rallied almost 46 per cent from our last buy call given in March 2019,